AstraZeneca’s Asthma Injection Helps Lungs in Advanced Tests

Updated on
  • Patients’ lung function improved four weeks after first shot
  • Benralizumab to enter crowded field led by Glaxo, Teva drugs

An AstraZeneca Plc injection helped boost lung function and relieve the symptoms of patients with severe asthma in two advanced clinical trials, paving the way for a regulatory submission later this year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.